Quest Diagnostics (DGX) recently entered into a definitive agreement to acquire one of the leading nonprofit health systems and academic medical centers in the United States. The company will purchase select assets of University Hospitals' ("UH") outreach laboratory services business, expanding access to innovative, quality diagnostic information services to drive affordable healthcare in Ohio. The latest transaction is expected to be completed in the fourth quarter of 2024, subject to the customary regulat ...

SECAUCUS, N.J. and TORONTO, Aug. 26, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the completion of its acquisition of LifeLabs from OMERS. The transaction, valued at approximately CAN $1.35 billion (approximately USD $1 billion), including net debt, has received all necessary approvals and is now closed. LifeLabs Logo (PRNewsfoto/Quest Diagnostics)LifeLabs Logo (PRNewsfoto/Quest Diagnostics) "This acquisition brings together two ...

A month has gone by since the last earnings report for Quest Diagnostics (DGX) . Shares have added about 6.3% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Quest Diagnostics due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. Quest Diagnostics Beats Q2 Earnings, Rais ...

Have you been paying attention to shares of Quest Diagnostics (DGX) ? Shares have been on the move with the stock up 6.3% over the past month. The stock hit a new 52-week high of $153.07 in the previous session. Quest Diagnostics has gained 10.9% since the start of the year compared to the 11.2% move for the Zacks Medical sector and the 15.1% return for the Zacks Medical - Outpatient and Home Healthcare industry. What's Driving the Outperformance? The stock has an impressive record of positive earnings surp ...

Transaction to broaden access to innovative, quality diagnostic information services powering affordable care in Ohio SECAUCUS, N.J., and CLEVELAND, Aug. 21, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, and University Hospitals, one of the nation's leading nonprofit health systems and academic medical centers, today announced a definitive agreement for Quest to acquire select assets of University Hospitals' outreach laboratory services business. ...

Quest Diagnostics (DGX) recently introduced 13 blood tests designed to evaluate micronutrient deficiencies, enabling people to determine if they are lacking certain vitamins and minerals required to maintain optimal health. These panels are now available for consumer purchase exclusively on questhealth.com. The recent development underscores the company's dedication to offering accessible, personalized and consumer-driven health insights that can make a meaningful difference in daily lives. Quest Diagnostic ...

SECAUCUS, N.J., Aug. 15, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX) (the "Company"), a leader in diagnostic information services, today announced the pricing of a public offering of $400 million aggregate principal amount of its 4.600% senior notes due 2027 (the "2027 notes"), $600 million aggregate principal amount of its 4.625% senior notes due 2029 (the "2029 notes") and $850 million aggregate principal amount of its 5.000% senior notes due 2034 (the "2034 notes," and together with t ...

Quest Diagnostics (DGX) , in collaboration with the University of Alabama, conducted a study that suggests adherence to guideline-based laboratory testing and treatment of pregnant women for two of the most prevalent sexually transmitted infections (STIs) is suboptimal in the United States. This could potentially result in dire effects on maternal and newborn health. The study, titled "Chlamydia and gonorrhea testing in pregnancy: Time to improve adherence and update recommendations", was published in the p ...

Lab tests offer insights for individuals who may experience inadequate intake of essential nutrients due to dietary restrictions, certain prescription medications, or chronic health conditions SECAUCUS, N.J., Aug. 15, 2024 /PRNewswire/ -- Micronutrients are essential vitamins and minerals that are vital for well-being and disease prevention, but deficiencies can commonly be caused by food allergies and dietary restrictions, certain prescription medications, or chronic health conditions. At least one in thre ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use a variety of methods, including tried- ...